Syneron Medical Ltd. (NASDAQ: ELOS) has announced that it has received the United States Food and Drug Administration (FDA) 510(k) clearance to market the UltraShape™ System for non-invasive reduction of abdominal circumference...
Read MoreRosalind Hill reviews some of the hair removal devices on the market and speaks to industry experts about the increasing popularity of at-home beauty devices
Read MoreSyneron-Candela has launched the fourth generation of its VelaShape device, the VelaShape III. The device, which has been launch simultaneously in the UK and US (to be followed by Europe),...
Read MoreIndustry experts share their thoughts on Syneron’s new VelaShape III device for non-invasive body shaping, including achieving maximum results and the benefits of pulse stacking
Read More
